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A B S T R A C T
The aim of the present studywas to evaluate the tolerability and efﬁcacy of themodiﬁed Atkins diet given
to children and adolescents with antiepileptic drug (AED) treatment resistant epilepsy.
15 children with medically intractable epilepsy were enrolled in the study. Inclusion criteria were at
least one seizure a week and a trial of at least two AEDs without obtaining seizure freedom documented
in a seizure calendar.
At baseline subjects initiated a diet with carbohydrates restricted to make up 10 energy percent. If
seizures were reduced by less than 50% after 7–14 days carbohydrates were further restricted to 10 g per
day. No change in AED treatment was allowed.
The diet waswell tolerated. After 3months six out of the ﬁfteen children (40%) had a seizure reduction
of more than 50%, which was seen in different epileptic syndromes and different age groups. The
responders reported an increase in quality of life and cognition. At 12 months follow-up 3 (20%)
continued the diet with an unchanged marked seizure reduction.
The present study conﬁrms the high tolerability and effect of the modiﬁed Atkins diet on seizure
control in AED treatment resistant epilepsy. Further larger prospective studies are however needed to
conﬁrm these results.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The ketogenic diet was originally developed in USA in the early
1920s. After the appearance of effective treatment with anti-
epileptic drugs like phenytoin and carbamazepine, the diet was
more or less forgotten until the late 1990s, when it was
reintroduced. Treatment with the diet has since then become
increasingly accepted internationally and it is today considered an
important alternative to antiepileptic drug therapy in young
children with medically intractable seizures.1 The ketogenic diet is
however difﬁcult to introduce to older children and adolescents2
and requires the parents to be highly motivated in order to
successfully maintain this very restricted diet. One study showed
that less than 10% continued the diet at 12 months follow-up
probably because of loss of compliance.3
The modiﬁed Atkins diet is a less restrictive alternative to the
traditional ketogenic diet, which allows an unlimited protein and
fat intake and does not restrict calorie or ﬂuid intake.* Corresponding author at: Clinic of Child Neurology, Bledamsvej 9, Rigshospita-
let, 2100 Copenhagen, Denmark. Tel.: +45 35455096; fax: +45 35456717.
E-mail address: pu@rh.dk (P. Uldall).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.10.004Recent studies of the modiﬁed Atkins diet at two different
centers have shown that it is an effective and well-tolerated
treatment in children.4–7
The aim of the present study was to evaluate the immediate
tolerability and efﬁcacy of treatment with a modiﬁed Atkins diet
given in a European country for 3 months to medically intractable
children and adolescents with epilepsy. Further, a 12-month
follow-up evaluation has been added to the study.
Methods
Subjects
15 children (6 female, 9 male) aged 2–17 years at diet onset
(median 10 years) with medically intractable childhood epilepsy
were enrolled from November 2006 until February 2007. Three of
the childrenwere on awaiting list for the classical ketogenic diet at
the time of enrolment. Of the remaining children none of their
parents had speciﬁcally asked for treatment with the ketogenic
diet or the Atkins diet. They were all enrolled in the study via an
ordinary outpatient clinic.
Including criteria were aminimumof oneweekly seizure of any
type, a trial of at least two relevant antiepileptic drugs (AED)vier Ltd. All rights reserved.
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calendar. In children with many daily seizures an estimated
number was calculated from counting seizures for 1 or 2 h at a
speciﬁc time every day. A variety of epilepsy syndromes were
included.
10 patients were treated at Dianalund Epilepsy Center, 4 at
Rigshopitalet and 1 at Hvidovre Hospital. Oral and written
informed consent was obtained from all families prior to initiation
of the study, which was approved by the Ethical Committee of
Copenhagen and Frederiksberg Municipalities ((KF) 01 320592).
Diet principles
In the out patient clinic parents were instructed to use a
formula to calculate the content of carbohydrates from labels on
food products. This formula helped parents control the daily
carbohydrate content of their children’s diet, so that dietician
counselling was not needed on a daily basis.
Carbohydrates were restricted to make up 10 energy percent
and restricted further to 10 g per day after 7–14 days, if seizures
were not reduced by >50% by then. Patients were further
encouraged to use ﬁbre supplements and to choose ﬁbrous
carbohydrates as fruit and vegetables to avoid constipation as a
side effect. No restrictions were givenwith regard to energy, ﬂuids,
proteins and fats intake, however intake of fats were encouraged. If
marginal efﬁcacy was observed an increased intake of lipids was
encouraged.
4 daily meals each containing 25% of the daily carbohydrate
contents were recommended. No restrictions were given on
carbohydrate freemeals. Intake of low-carbohydrate products (e.g.
candy bars, baking mixes) was discouraged for at least the ﬁrst
month. Especially carbohydrate-free soft drinks, pork crackling
and carbohydrate-free jelly were suggested as alternatives to
sweets. Further, vitamin and mineral supplementation was
recommended.
The same dietician (SW) was responsible for all contacts with
the families throughout the study period. An estimation of time
spent by the dietician and the medical doctors showed that an
average of 45 min at the ﬁrst visit and 30 min at each of the
following visits was used. In addition approximately 6 h were
spent on each family for telephone and email correspondences.
Upon completion of the study parents were invited to continue
the diet supported by their regular dietician, if the child had
experienced a reduction in seizures including children with less
than 50% seizure reduction. Adjustment in AED treatment was
allowed and contact to dietician and out patient clinics was
reduced to once every third month.
Design
All patients were evaluated at baseline and every month for 3
months in total. Blood tests included liver enzymes, cholesterol
and triglyceride. Before entering the study plasma carnitine andTable 1
Study design.
Baseline 1-month 2-m
Diet information Diet adjustments Diet
Diet instruction Seizure registration Seiz
Registration of last months number of seizures Grade of ketosis Grad
Blood test Blood tests Bloo
Weight Weight Wei
Diet initiation when blood tests were cleared
Parents motivation, the child’s appetite
QOL and cognitionurine were analysed to exclude any neurometabolic disorder. The
diet was regularly followed up by the dietician via e-mail or
telephone. No change in AED treatment was allowed. Parents were
asked to measure urinary ketones on a daily basis for the ﬁrst
month of the study and weekly from the second month and
throughout the study (Table 1).
Parents were instructed to use a visual analogue scale (VAS) to
assess cognition, quality of life and appetite of their children as
well as their own motivation at the beginning and 3 months after
initiation of the diet.
VAS scores were converted into percentage, the highest
percentage being a positive statement and the lowest percent
being a negative.
A follow-up was performed at 12 months. The follow-up
comprised a case note search and a clinical visit for the children
still treated with the diet.
Statistics
Means were compared using a two sample paired Students
t-test, and level of signiﬁcance was set at p  0.05. Tests were
performed using Excel Ofﬁce for Mac 2004.
Results
Three children (20%) did not complete the study. Two were
excluded within the ﬁrst month of the study because of change in
AED treatment (no effect on seizures and intolerable high seizure
frequency). One of these patients changed to the ketogenic diet
without efﬁcacy. The third patient stopped after 2 months because
of no efﬁcacy of the diet. Two patients (13%) stopped because of
side effects after completion of the 3 months trial.
Six of the 15 (40%) were responders with a seizure reduction of
more than 50% after 3 months. Seizure reduction was seen in a
variety of different epileptic syndromes as well as different age
groups (Table 2).
At 10 energy percent 14 children (93%) measured ketones. One
patient excluded early in the study did not measure ketones.
Moderate urinary ketosis appeared in 12 (86%) of the 14 children
within 10 days (mean 2.9 days). Two children (14%) developed only
mild ketosis.
At 10 g carbohydrate 13 children (87%) measured ketones. Mild
to moderate ketosis continued. Only few times strong ketosis
appeared and never for a longer period. Parents reported no
correlation between degree of ketosis and seizure reduction.
All except one child reduced their daily carbohydrate intake
from 10 energy percent to 10 g. This child (no. 12) had a >50%
reduction in seizures despite the high carbohydrate intake of 10
energy percent (32 g per day). Patients who were non-responders
and increased lipid intake did not improve seizure control.
Four patients reported side effects of the treatment but all of
them completed the study. Three felt constipated and one
complained of nausea.onth 3-month
adjustments Diet adjustments
ure registration Seizure registration
e of ketosis Grade of ketosis
d tests Blood tests
ght Weight
Parents motivation, the child’s appetite QOL and cognition
3 days weighed dietary calendar
Table 2
Patient characteristics and outcome of a 3 months trial with a modiﬁed Atkins diet.
Patient Syndrome Mental retardation Age Monthly seizure
number before
Monthly seizure
number after
% reduction
1 LG + 6 30 – –
2 MAE + 14 37 38 0
3 SF + 9 10 10 0
4a CAE  11 210 30 >85
5a MAE + 3 300 10 >90
6 SF  2 600 – –
7 SF  12 600 450 25
8a SF + 12 44 21 >50
9 SF + 15 25 21 0
10 LG + 11 180 180 0
11 LG + 5 25 – –
12a MAE + 15 540 30 >90
13a SF + 10 150 60 >50
14a JME  17 150 30 >75
15 SF  13 60 60 0
SF, symptomatic focal; LG, Lennox Gastaut; MAE, myoclonic astatic epilepsy; CAE, childhood absence epilepsy; JME, juvenile myoclonic epilepsy.
a Responders.
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(S.D.  1.5) (p = 0.02). Triglycerides were 1.03 mmol/l (S.D.  0.41) at
baseline and 1.29 mmol/l (S.D.  0.75) (p = 0.28) after 3 months.
The weight increased with a mean of 0.7 kg during the study
period. Themeanweightwas 41.8 kg at baseline and 42.8 kg after 3
months (p = 0.41). Eight children lost weight with a median of
0.5 kg (range, 0.1–6.5 kg) and ﬁve gained weight with a median of
2.35 kg (range, 0.1–4.1 kg). Two of those who lost weight were
overweight at start of the study.
11 parents assessed the cognition of their children, quality of
life and appetite at baseline and after 3 months by VAS (Tables 3
and 4). 10 parents assessed their own motivation in relation to
beginning the diet, also by VAS. Responders increased their
cognition and quality of life, while their motivation and appetite
was unchanged. In non-responders motivation and appetite
decreased while quality of life and cognition in general were
unchanged throughout the study period.
All children with less than 50% seizure reduction stopped the
diet after 3 months. At the 12 months follow-up three patients
(patient no. 5, no. 12, no. 14) had continued the diet with the same
or even an increased seizure reduction compared to the 3 months
follow-up. One of these patients (no. 14) had tapered her
antiepileptic drug. The remaining three responders stopped the
diet after 5–8 months as parents and the children felt that the
obtained seizure reduction was not enough to motivate a
continuation.
Discussion
This study has shown that 12 of 15 children continued a
modiﬁed Atkins diet for 3 months in a population of rather old
children (mean age 10) and in a setting with few supportive
resources when compared to the classical ketogenic diet. ExceptTable 3
Quality of life (QOL), cognition, motivation and appetite measured by visual
analogue scale (VAS) at baseline and at 3 months follow-up in responders to the
diet.
Responders (6 patients) Baseline (%) Follow-up (%)
QOL 43 68
Cognition 53 68
Motivation 97 94
Appetite 66 67
Data are presented in mean percent.for three children enrolled from the ketogenic diet waiting list,
parents had no special motivation for diet intervention but
complied well. This indicates that the diet is tolerable and thus
might become amorewidely used alternative treatment compared
to the classical ketogenic diet. Similar studies have reported a
frequency of 80% and 64% of subjects continuing their diets at 3
months follow-up.6,7
Using an intent to treat analysis six of 15 children (40%) had
more than 50% seizure reduction after 3 months. This is rather
similar to the above-mentioned studies. Kossoff et al.6 showed that
children starting the diet at 10 g carbohydrate per day had a
signiﬁcantly higher likelihood of more than 50% seizure reduction
when compared to children starting at 20 g carbohydrate per day.
The authors therefore suggested the opposite strategy as in our
study. Comparing the results at 3 months follow-up at John
Hopkins Hospital resulted in comparable ﬁgures between the
modiﬁed Atkins diet and the classical ketogenic diet.5 Larger and
more studies are however needed in order to clarify a possible
difference in treatment effect between the two diets.
The present study is the ﬁrst to provide a 12 months follow-up
with 3 out of 15 (20%) patients continuing the diet. Themaintained
efﬁcacy of the diet treatment must be seen in the light of the
patient population consisting of children who are difﬁcult to treat.
It is not easy to ﬁnd comparable add-on studies on the efﬁcacy
of introducing a new antiepileptic drug in children with ongoing
seizures despite treatment. Two studies with a follow-up of 12
months found that 40% (vigabatrin) and 31% (levetiracetam) had
>50% seizure reduction.8,9 One study gave results at 18 months
follow-up and had 32% with >50% seizure reduction (zonisamide)
while a study with 24 months follow-up found that 23%
(topiramate) had >50% seizure reduction.10,11 It is difﬁcult to
compare the severity of the epilepsy of the children involved,
however.Table 4
Quality of life (QOL), cognition, motivation and appetite measured by visual
analogue scale (VAS) at baseline and at 3 months follow-up in non-responders to
the diet.
Non-responders (5 patients) Baseline (%) Follow-up (%)
QOL 49 39
Cognition 49 50
Motivation 94 52
Appetite 54 42
Data are presented in mean percent.
S. Weber et al. / Seizure 18 (2009) 237–240240Our study population included a 17-year-old girl (no. 14) who
continued the diet at 12 months follow-up. She managed the diet
herself, went on holiday and cafe´s with her friends and even
tapered Lamictal treatmentwithout loosing control of her seizures.
The ﬁrst trial of the modiﬁed Atkins diet for 30 adults revealed
that 33% had more than 50% seizure reduction after 6 months of
treatment.12 A smaller European study on adults also concluded
that the diet is feasible in adults.13
As expected the quality of life, cognition, motivation and
appetite were rated high at 3 months follow-up among responders
compared to non-responders. One study have found that quality of
lifemight improve evenwith seizure reduction less than 50% in the
classical ketogenic diet.14
Since the Atkins diet originally was created in order to loose
weight it is reassuring that themeanweight of the childrenwas the
same at baseline and at the 3 months follow-up. We found a
signiﬁcant increase in cholesterol which was however small, while
triglycerides were unchanged. These ﬁndings are in accordance
with another study testing the Atkins diet.6
Few children and parents had speciﬁc complaints concerning
the diet. At the 3 months follow-up it was however obvious that
only those with a substantial seizure reduction chose to continue
the diet.
Levels of ketones increased somewhat when the intake of
carbohydrate decreased, but though ketones are widely used as
markers of seizure control, our ﬁndings support that a high ketosis
per se is not always essential for an improvement in seizure
control.
This small study conﬁrms the positive effect of the modiﬁed
Atkins diet on seizure control in AED treatment resistant epilepsy
and further provides encouraging results regarding seizure control
at the 12 months follow-up. Larger prospective studies are neededto conﬁrm these results including a comparison between the
ketogenic diet and the modiﬁed Atkins diet.
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